Clinical Trial Update: Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EN3835 versus placebo for plantar fibromatosis has completed and posted results, reporting on efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Fibromatosis

Drugs mentioned

• EN3835

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Plantar Fibromatosis | Phase 2 | Status: COMPLETED | Results posted: 2026-03-27